Company profile for SK Biopharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SK Biopharmaceuticals commenced research and development of new drugs in 1993 as part of our search for the next-generation growth engine of SK Group. The exciting ascend of SK Biopharmaceuticals began with the acquisition of FDA approval for clinical test for a new candidate drug substance in 1996. * Investigational New Drug (IND) application: Application for approval of clinical tests on candidate substance, of which safety...
SK Biopharmaceuticals commenced research and development of new drugs in 1993 as part of our search for the next-generation growth engine of SK Group. The exciting ascend of SK Biopharmaceuticals began with the acquisition of FDA approval for clinical test for a new candidate drug substance in 1996. * Investigational New Drug (IND) application: Application for approval of clinical tests on candidate substance, of which safety and efficacy have been verified in the preliminary clinical test, by testing them on human subjects

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
221 Pangyoyeok-ro Bundang-gu Seongnam-Si, 13494 Korea, Republic of (South)
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/rd/sk-biopharmaceuticals-acquires-exclusive-global-rights-for-warf-cancer-drug-candidate-18414

INDPHARMAPOST
01 Dec 2025

https://www.prnewswire.com/news-releases/sk-life-science-inc-announces-publication-of-c035-study-analyses-in-epilepsia-and-seizure-302616095.html

PR NEWSWIRE
17 Nov 2025

https://www.prnewswire.com/news-releases/sk-biopharmaceuticals-launches-joint-venture-with-eurofarma-for-ai-based-epilepsy-management-platform-302589583.html

PR NEWSWIRE
21 Oct 2025

https://www.fiercepharma.com/pharma/sks-blockbuster-hopeful-xcopri-reduces-seizures-phase-3-trial-teeing-fda-expansion-bid

FIERCE PHARMA
17 Sep 2025

https://www.prnewswire.com/news-releases/sk-life-science-labs-announces-the-publication-in-nature-communications-of-its-breakthrough-research-on-molecular-glue-discovery-to-advance-cancer-immunotherapy-302444649.html

PR NEWSWIRE
01 May 2025

https://www.prnewswire.com/news-releases/sk-life-science-inc-to-showcase-important-xcopri-cenobamate-tablets-cv-data-on-responsive-neurostimulation-epileptiform-events-at-the-77th-american-academy-of-neurology-aan-annual-meeting-302420275.html

PR NEWSWIRE
04 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty